Trials / Unknown
UnknownNCT04095312
Clinical Study for Evaluating the Clinical Safety and Effectiveness of the Automated Robotic Robot, Revo-i Surgical Robot System (Model MSR-5100), Used for General Endoscopic Surgery.
A Prospective, Single-center, Single-group Clinical Study for Evaluating the Clinical Safety and Effectiveness of the Automated Robotic Robot, Revo-i Surgical Robot System (Model MSR-5100), Used for General Endoscopic Surgery.
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 33 (estimated)
- Sponsor
- Yonsei University · Academic / Other
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
This study is based on the ergonomic features of the most common surgical procedures, which require advanced techniques and relatively difficult operations, such as pancreatobiliary surgery, prostatectomy, nephrectomy, colon and rectal resection. This study id designed to verify the clinical safety and effectiveness of 'Revo-i Surgical Robot System (Model MSR-5100), developed by Mirae Company to overcome the limitations of general laparoscopic surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Revo-i robotic surgery system (Model MSR-5100) | for evaluating the clinical safety and effectiveness of the automated robotic robot, Revo-i Surgical Robot System (Model MSR-5100), used for general HBP surgery |
| PROCEDURE | Revo-i robotic surgery system (Model MSR-5100) | for evaluating the clinical safety and effectiveness of the automated robotic robot, Revo-i Surgical Robot System (Model MSR-5100), used for general Uro surgery |
| PROCEDURE | Revo-i robotic surgery system (Model MSR-5100) | for evaluating the clinical safety and effectiveness of the automated robotic robot, Revo-i Surgical Robot System (Model MSR-5100), used for general colorectal surgery |
Timeline
- Start date
- 2019-09-17
- Primary completion
- 2020-03-01
- Completion
- 2020-04-01
- First posted
- 2019-09-19
- Last updated
- 2019-09-30
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04095312. Inclusion in this directory is not an endorsement.